J 2006

Structural Characterization, DNA Interactions, and Cytotoxicity of New Transplatin Analogues Containing One Aliphatic and One Planar Heterocyclic Amine Ligand

RAMOS-LIMA, Francisco J., Oldřich VRÁNA, Adoración G. QUIROGA, Carmen NAVARRO-RANNINGER, Anna HALÁMIKOVÁ et. al.

Basic information

Original name

Structural Characterization, DNA Interactions, and Cytotoxicity of New Transplatin Analogues Containing One Aliphatic and One Planar Heterocyclic Amine Ligand

Name in Czech

Strukturní charakterizace, interakce s DNA, a cytotoxicita nových transplatinových analogů obsahujících jeden alifatický a jeden heterocyklický amino ligand

Authors

RAMOS-LIMA, Francisco J. (724 Spain), Oldřich VRÁNA (203 Czech Republic), Adoración G. QUIROGA (724 Spain), Carmen NAVARRO-RANNINGER (724 Spain), Anna HALÁMIKOVÁ (703 Slovakia), Hana RYBNÍČKOVÁ (203 Czech Republic), Lenka HEJMALOVÁ (203 Czech Republic) and Viktor BRABEC (203 Czech Republic, guarantor)

Edition

Journal of Medicinal Chemistry, USA, American Chemical Society, 2006, 0022-2623

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

10610 Biophysics

Country of publisher

United States of America

Confidentiality degree

není předmětem státního či obchodního tajemství

Impact factor

Impact factor: 5.115

Organization unit

Faculty of Science

UT WoS

000236979100029

Keywords (in Czech)

transplatina; protinádorový; DNA

Keywords in English

transplatin; antitumor; DNA

Tags

International impact, Reviewed
Změněno: 22/6/2009 14:15, Mgr. Lenka Hejmalová

Abstract

V originále

We report in the present work new analogues of clinically ineffective transplatin in which one ammine group was replaced by aliphatic and the other by a planar heterocyclic ligand, namely trans-[PtCl(2)(isopropylamine)(3-(hydroxymethyl)-pyridine)], 1, and trans-[PtCl(2)(isopropylamine)(4-(hydroxymethyl)-pyridine)], 2. The new compounds, in comparison with parent transplatin, exhibit radically enhanced activity in tumor cell lines both sensitive and in particular resistant to cisplatin. Concomitantly, the DNA binding mode of 1 and 2 compared to parent transplatin and other antitumor analogues of transplatin in which only one ammine group was replaced is also different. The results also suggest that the reactions of glutathione and metallothionein-2 with compounds 1 and 2 do not play a crucial role in their overall biological effects. In addition, the monofunctional adducts of 1 and 2 are quenched by glutathione considerably less than the adducts of transplatin, which may potentiate cytotoxic effects of these new platinum complexes.

In Czech

Tato práce popisuje nové analogy klinicky neúčinné tranplatiny, kde je nahrazena jedna aminoskupina alifatickým řetězcem a druhá aminoskupina je nahrazena planárním heterocyklickým ligantem,a to trans-[PtCl(2)(isopropylamine)(3-(hydroxymethyl)-pyridine)], 1, and trans-[PtCl(2)(isopropylamine)(4-(hydroxymethyl)-pyridine)], 2.